ICON Public Limited (NASDAQ:ICLR) Short Interest Update

ICON Public Limited (NASDAQ:ICLR) saw a large increase in short interest in June. As of June 15th, there was short interest totalling 2,100,000 shares, an increase of 7.1% from the May 31st total of 1,960,000 shares. Approximately 2.6% of the shares of the company are short sold. Based on an average trading volume of 511,600 shares, the days-to-cover ratio is currently 4.1 days.

ICON Public Stock Performance

ICON Public stock traded up $1.79 during mid-day trading on Tuesday, hitting $318.30. 645,057 shares of the company’s stock traded hands, compared to its average volume of 583,932. The firm has a 50 day moving average price of $315.40 and a 200 day moving average price of $302.74. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.36. The company has a market cap of $26.26 billion, a PE ratio of 38.72, a price-to-earnings-growth ratio of 1.40 and a beta of 1.23. ICON Public has a one year low of $221.20 and a one year high of $344.77.

ICON Public (NASDAQ:ICLR) last announced its earnings results on Wednesday, April 24th. The medical research company reported $3.38 earnings per share for the quarter, beating the consensus estimate of $3.30 by $0.08. The firm had revenue of $2.09 billion for the quarter, compared to the consensus estimate of $2.09 billion. ICON Public had a return on equity of 11.70% and a net margin of 8.30%. On average, equities analysts forecast that ICON Public will post 14.52 EPS for the current year.

Institutional Trading of ICON Public

Hedge funds and other institutional investors have recently modified their holdings of the company. Bruce G. Allen Investments LLC bought a new stake in shares of ICON Public in the 4th quarter worth $25,000. Livelsberger Financial Advisory bought a new stake in shares of ICON Public in the 4th quarter worth $29,000. Pinnacle Bancorp Inc. raised its stake in shares of ICON Public by 110.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 105 shares of the medical research company’s stock worth $30,000 after buying an additional 55 shares in the last quarter. Riverview Trust Co bought a new stake in shares of ICON Public in the 1st quarter worth $31,000. Finally, GAMMA Investing LLC bought a new stake in shares of ICON Public in the 4th quarter worth $37,000. Institutional investors own 95.61% of the company’s stock.

Analysts Set New Price Targets

ICLR has been the subject of several research reports. TD Cowen lifted their target price on ICON Public from $349.00 to $373.00 and gave the stock a “buy” rating in a research report on Friday, May 31st. The Goldman Sachs Group initiated coverage on ICON Public in a research report on Thursday, June 6th. They issued a “buy” rating and a $370.00 target price for the company. Robert W. Baird lifted their target price on ICON Public from $363.00 to $367.00 and gave the stock an “outperform” rating in a research report on Friday, May 31st. Mizuho reissued a “buy” rating and issued a $346.00 price target on shares of ICON Public in a report on Thursday, April 4th. Finally, Evercore ISI cut their price target on ICON Public from $350.00 to $330.00 and set an “outperform” rating on the stock in a report on Friday, April 26th. One research analyst has rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $345.30.

ICON Public Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.